Engineering de novo anthocyanin production in Saccharomyces cerevisiae by Levisson, M. et al.
Levisson et al. Microb Cell Fact  (2018) 17:103  
https://doi.org/10.1186/s12934-018-0951-6
RESEARCH
Engineering de novo anthocyanin 
production in Saccharomyces cerevisiae
Mark Levisson1†, Constantinos Patinios1†, Sascha Hein2†, Philip A. de Groot3, Jean‑Marc Daran3 , 
Robert D. Hall1,4, Stefan Martens2  and Jules Beekwilder4* 
Abstract 
Background: Anthocyanins are polyphenolic pigments which provide pink to blue colours in fruits and flowers. 
There is an increasing demand for anthocyanins, as food colorants and as health‑promoting substances. Plant produc‑
tion of anthocyanins is often seasonal and cannot always meet demand due to low productivity and the complex‑
ity of the plant extracts. Therefore, a system of on‑demand supply is useful. While a number of other (simpler) plant 
polyphenols have been successfully produced in the yeast Saccharomyces cerevisiae, production of anthocyanins has 
not yet been reported.
Results: Saccharomyces cerevisiae was engineered to produce pelargonidin 3‑O‑glucoside starting from glucose. Spe‑
cific anthocyanin biosynthetic genes from Arabidopsis thaliana and Gerbera hybrida were introduced in a S. cerevisiae 
strain producing naringenin, the flavonoid precursor of anthocyanins. Upon culturing, pelargonidin and its 3‑O‑glu‑
coside were detected inside the yeast cells, albeit at low concentrations. A number of related intermediates and side‑
products were much more abundant and were secreted into the culture medium. To optimize titers of pelargonidin 
3‑O‑glucoside further, biosynthetic genes were stably integrated into the yeast genome, and formation of a major 
side‑product, phloretic acid, was prevented by engineering the yeast chassis. Further engineering, by removing two 
glucosidases which are known to degrade pelargonidin 3‑O‑glucoside, did not result in higher yields of glycosylated 
pelargonidin. In aerated, pH controlled batch reactors, intracellular pelargonidin accumulation reached 0.01 µmol/
gCDW, while kaempferol and dihydrokaempferol were effectively exported to reach extracellular concentration of 
20 µM [5 mg/L] and 150 µM [44 mg/L], respectively.
Conclusion: The results reported in this study demonstrate the proof‑of‑concept that S. cerevisiae is capable of de 
novo production of the anthocyanin pelargonidin 3‑O‑glucoside. Furthermore, while current conversion efficiencies 
are low, a number of clear bottlenecks have already been identified which, when overcome, have huge potential to 
enhance anthocyanin production efficiency. These results bode very well for the development of fermentation‑based 
production systems for specific and individual anthocyanin molecules. Such systems have both great scientific value 
for identifying and characterising anthocyanin decorating enzymes as well as significant commercial potential for the 
production of, on‑demand, pure bioactive compounds to be used in the food, health and even pharma industries.
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Background
Anthocyanins are water-soluble pigments that colour the 
leaves, fruit and flowers of many plant species. Despite 
the small number of aglycones (anthocyanidins) pro-
duced by the plant kingdom, very many different antho-
cyanins have been identified and distinguished by their 
unique degree of decoration achieved by methylation, 
glycosylation and acylation with both aliphatic and aro-
matic groups. These decorations convey a contrasting 
set of characteristics to the molecules (stability, solubil-
ity, bioavailability, anti-oxidant properties, etc.) and have 
direct relevance to their importance in a food/health 
context. In our diet, anthocyanins occur as pigments [1], 
but anthocyanins and their derivatives are increasingly 
being considered as interesting bioactive compounds 
with various health promoting effects [2]. This is sup-
ported by many more recent studies of anthocyanin-rich 
fruits, such as blueberry and cranberry [3]. Their relative 
abundance in the diet and their potency against a range 
of chronic diseases have made anthocyanins the subject 
of intense research in experimental and preventive medi-
cine. Furthermore, more recently there is a fast-growing 
market demand for formulating natural colours [4]. The 
limited range of commercially-available anthocyanins 
and the expense of making pure preparations means that 
most research has been done only using crude extracts 
of plants. These plant-derived anthocyanin extracts are 
typically not standardised with respect to the particular 
anthocyanins they contain, nor to the amounts of each 
anthocyanin in the extract. Variations in anthocyanin 
decoration account for differences in colour stability and 
pigment hue and this underpins the growing need for 
developing systems for the production of pure anthocya-
nins, for investigating the effects of chemical specificity 
on uptake, signalling and physiology, toxicity of antho-
cyanins for medical applications and for developing new 
formulations for the food pigment industries [5].
The anthocyanin pathway is one of best understood 
and characterized pathways in plant secondary metabo-
lism both in genetic as in chemical/enzymatic terms 
[6]. It branches from the flavonoid pathway after the 
formation of flavanones, such as naringenin and erio-
dictyol (Fig.  1). The availability of genes for the entire 
pathway opens up the possibility for the expression of 
the full plant biosynthetic pathway in a microbial host 
and hence create a sustainable tailor-made platform for 
the biotechnological production of specific anthocyanin 
derivatives. Naringenin is synthesized via the phenylpro-
panoid pathway, starting from the aromatic amino acids 
phenylalanine or tyrosine. Yeast strains engineered with 
the pathway towards naringenin have been described [7, 
8]. Starting from naringenin, anthocyanidins are biosyn-
thesized by flavanone 3-hydroxylase (F3H; syn. FHT), 
dihydroflavonol 4-reductase (DFR), and anthocyanidin 
synthase (ANS; syn. leucoanthocyanidin dioxygenase). 
ANS has been characterized as a multifunctional protein 
catalysing several reactions with different flavonoid sub-
strate intermediates [9, 10]. The final step towards a basic 
anthocyanin is catalysed by an anthocyanin 3-O-gluco-
syltransferase (3GT). Other modifications of the antho-
cyanidin skeleton can be introduced at different points 
in this pathway, for instance by the action of flavonoid 
hydroxylases, methyltransferases, other glycosyltrans-
ferases and acyltransferases [11].
Anthocyanin production has been achieved in Escheri-
chia coli, by introducing parts of the anthocyanin bio-
synthetic pathway and by supplementing the growth 
medium with precursors such as coumaric acid, narin-
genin, catechin, or eriodyctiol [12–16]. Several strategies 
have been developed to improve further the anthocya-
nin yield in this system, including a higher availability 
of UDP-glucose, redirecting the carbon metabolism to 
malonyl-CoA and optimizing cultivation parameters. 
These led to the production of the anthocyanin cyanidin 
3-O-glucoside (C3G) at a titer of 350 mg/L [15]. Recently, 
a four-strain E. coli polyculture was used to obtain de 
novo production of pelargonidin 3-O-glucoside at a titer 
of 9.5 mg/L [17]. However, despite improvements at the 
genetic and cultivation levels, the construction of a single 
microbial strain capable of producing de novo anthocya-
nins and utilizing a simple carbon source has not been 
reported.
In a previous work, we developed strains of the yeast S. 
cerevisiae that were capable of producing 400 µM narin-
genin in their culture medium [7]. In the present study, 
this platform has been expanded towards the produc-
tion of the anthocyanidin pelargonidin and its glucoside, 
pelargonidin 3-O-glucoside. A number of limitations of 
the established system were revealed by the detection of 
side-products in the cultures, and attempted solutions to 
these limitations are discussed.
Results
Selection of genes necessary for the synthesis 
of anthocyanins in S. cerevisiae
In previous work, the S. cerevisiae strain IMX106 had 
been engineered to produce naringenin and was reported 
to produce up to 46.5 µM of the flavonoid [7]. In order 
to convert naringenin into the anthocyanin pelargo-
nidin 3-O-glucoside, four additional enzymatic steps 
are required (Fig.  1). To match the gene origin used to 
convert aromatic amino acids to naringenin in strain 
IMX106, which still has a number of auxotrophic mark-
ers available, the F3H, ANS and UGT78D2 (3GT) genes 
for anthocyanin biosynthesis were all, but DFR, recruited 
from A. thaliana. The A. thaliana DFR gene was not 
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Fig. 1 Representation of the integrated pelargonidin 3‑O‑glucoside biosynthesis pathway. Nine A. thaliana genes were overexpressed: PAL 
phenylalanine ammonia lyase, C4H cinnamate 4‑hydroxylase, CPR cytochrome P450 reductase, 4CL 4‑coumaric acid‑CoA ligase, CHS chalcone 
synthase, CHI chalcone isomerase, F3H flavanone 3‑hydroxylase, ANS anthocyanidin synthase, and 3GT anthocyanin 3‑O‑glucosyltransferase; one 
gene from G. hybrida: DFR dihydroflavonol 4‑reductase; and one gene from R. capsulatus: TAL tyrosine ammonia lyase. Enzyme names are in green. 
Bold dark blue arrows indicate the pelargonidin 3‑O‑glucoside biosynthesis pathway. Dashed lines indicate routes to side‑products produced by 
the catalytic activity of ANS, 3GT or the endogenous TSC13 (a very long chain fatty acid enoyl reductase)
Page 4 of 16Levisson et al. Microb Cell Fact  (2018) 17:103 
used because it is known only to accept dihydroquerce-
tin (DHQ) and dihydromyricetin (DHM) as substrates 
and is unable to convert the expected substrate in this 
system, dihydrokaempferol (DHK) into leucopelargoni-
din [14, 18] (Fig.  1). In contrast, the DFR gene from G. 
hybrida has been shown to use DHK and was, therefore, 
selected instead to complete the biosynthetic pathway 
[19]. Episomal expression vectors, carrying combinations 
of yeast codon-optimized versions of the A. thaliana 
F3H (coF3H), ANS (coANS), UGT78D2 (co3GT) and G. 
hybrida DFR (coGhDFR), were constructed.
The episomal expression vectors pF and pFD were 
constructed to analyse the first two steps of anthocyanin 
biosynthesis. These plasmids were transformed into the 
naringenin-producing strain IMX106, resulting in strains 
IMX106-F and IMX106-FD. These strains were cultured 
in shake-flasks with 10  mL synthetic medium supple-
mented with glucose as sole carbon source for 65  h, 
after which the total culture was extracted, and extracts 
analysed using HPLC. Strain IMX106-F was able to effi-
ciently produce DHK from naringenin (Table 1). Produc-
tion of DHK by strain IMX106-FD was comparable to 
strain IMX106-F, suggesting that DFR activity was very 
low. Nevertheless, production of leucoanthocyanidin 
could be detected via a colorimetric assay (see Additional 
file 1). To initiate the conversion of leucopelargonidin to 
pelargonidin the coANS gene was inserted into the pFD 
plasmid. The resulting strain IMX106-FDA showed to 
produce, not only pelargonidin, but also high amounts 
of the side product kaempferol (Table  1). The ratio 
between pelargonidin and kaempferol concentrations 
reached a value of 6.10−3 (Table 1). To improve the sta-
bility of pelargonidin, the co3GT gene encoding a gluco-
syltransferase was incorporated into the pFDA plasmid. 
The resulting strain IMX106-FDA3 was able to produce 
small amounts of pelargonidin 3-O-glucoside (Table  1). 
However, a second major side product was also detected 
and subsequently identified as kaempferol 3-O-glucoside 
(K3G). Approximately 30% of the produced kaempferol 
was glycosylated by 3GT, while only 10% of the produced 
pelargonidin was found to be glycosylated. Although sev-
eral conversions in this process apparently occur at sub-
optimal efficiency, this experiment nevertheless showed 
that de novo P3G production is indeed possible in S. 
cerevisiae.
Effect of different DFRs on P3G production
From the massive accumulation of DHK in the previ-
ous experiment it was evident that DFR activity is one of 
the bottlenecks in P3G production. Therefore, to engi-
neer efficient P3G biosynthesis in S. cerevisiae, we then 
selected and tested two additional yeast codon-optimized 
DFR enzymes (from Medicago truncatula and Anthurium 
andreanum) in addition to the DFR from G. hybrida, 
each of which had previously been shown to reduce DHK 
to leucopelargonidin [14, 18–20]. The episomal expres-
sion vectors pCPW002, pCPW006 and pCPW007 were 
constructed containing the coF3H, coANS, co3GT and 
the coGhDFR, coMtDFR or coAaDFR genes, respectively. 
These plasmids were transformed to strain IMK393 
(aro3Δ, ARO4G226S, pdc6Δ, pdc5Δ, aro10Δ), result-
ing in strains PATW002, PATW011, and PATW012. 
These strains were cultured in shake-flasks with SMNar 
(1.5  mM naringenin) and glucose as sole carbon source 
for 140 h. HPLC analysis of culture supernatant showed 
the production of DHK, while pelargonidin or P3G were 
not detected (Table  2). On the other hand, the two by-
products, kaempferol and kaempferol 3-O-glucoside, 
were detected in the culture supernatant. At the end 
of the 140  h, biomass was harvested and yeast cell pel-
lets were extracted (Fig.  2) and analysed for intracellu-
lar pelargonidin and P3G using HPLC and LC–MS. The 
strain PATW002, expressing coGhDFR, produced twice 
the amount of pelargonidin relative to strains PATW011 
and 012 (Table  2). Again, only traces of P3G could be 
detected, using LC–MS.
Table 1 Product formation of naringenin and downstream metabolites in S. cerevisiae strains.
Strains IMX106, IMX106-F, IMX106-FD, IMX106-FDA and IMX106-FDA3 were grown in 10 mL shake-flask cultures. The whole culture was extracted after 65 h of 
culturing at 30 °C. Metabolite concentrations of naringenin, dihydrokaempferol (DHK), kaempferol, kaempferol 3-O-glucoside (K3G), pelargonidin and pelargonidin 
3-O-glucoside (P3G) expressed in µM were measured by HPLC. Data represents the average ± mean deviation of independent biological triplicates
– not detected
µM IMX106 IMX106-F IMX106-FD IMX106-FDA IMX106-FDA3
Naringenin 23.4 ± 1.4 7.8 ± 0.1 7.7 ± 0.6 6.5 ± 0.3 3.1 ± 1.0
DHK – 18.5 ± 0.1 17.5 ± 0.9 8.5 ± 0.00 9.8 ± 0.8
Kaempferol – – – 11.7 ± 0.5 4.4 ± 1.0
K3G – – – – 2.3 ± 0.2
Pelargonidin – – – 0.07 ± 0.00 0.85 ± 0.03
P3G – – – – 0.05 ± 0.00
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Having established a genetic blueprint necessary for de 
novo synthesis of anthocyanins in S. cerevisiae, the next 
step was to express the selected gene set in an optimized 
metabolic chassis.
Optimization of a S. cerevisiae chassis for anthocyanin 
synthesis
Integration of the anthocyanin biosynthetic pathway 
in the yeast genome
Previously, S. cerevisiae was engineered for de novo nar-
ingenin production by introducing the naringenin bio-
synthetic genes from A. thaliana and optimizing the 
flux through the shikimate pathway [7]. This engineered 
yeast (IMX198) for naringenin production provides the 
metabolic chassis for the current study. This strain, how-
ever, relies on plasmid-based overexpression of genes. 
Direct integration of genes is more stable and reliable 
compared with plasmid-based overexpression. There-
fore, as a first step, a strain was created in which the 
biosynthetic genes towards naringenin (PAL, C4H, CPR, 
4CL, CHS and CHI) were integrated into the genome of 
S. cerevisiae strain IMK393, which carries a set a muta-
tions resulting in deregulation of the aromatic amino 
acid biosynthetic pathway and elimination of the Ehrlich 
pathway. Two separate genomic locations (X-2 and XII-
2) were selected to integrate the naringenin biosynthetic 
genes. Both locations have been previously validated for 
stable integration of multiple genes and strain fitness 
[21]. First, the atCHI1, atCHS3 and at4CL3 genes were 
integrated at the X-2 integration site of strain IMK393, 
resulting in strain PATW004. Subsequently, the atPAL1, 
coC4H, coCPR1, and coCHS3 genes were integrated 
into the XII-2 integration site of PATW004, resulting in 
strain PATW066. The newly constructed naringenin-
producing strain PATW066 (aro3Δ, ARO4G226S, pdc6Δ, 
pdc5Δ, aro10Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, 
atCHS3↑, coCHS3↑, at4CL3↑) exhibited flavonoid pro-
duction characteristics very similar to the IMX106 strain 
that was used to perform the anthocyanin genes selec-
tion (Table 3). HPLC analysis of the culture supernatant 
showed naringenin production up to a concentration of 
40 µM and production of phloretic acid up to 160 µM for 
both strains (Table  3). Thus strain PATW066 was used 
as the new naringenin-producing platform. In a second 
step, the genes coF3H, coGhDFR, coANS and co3GT were 
introduced in PATW066 by integration at the CAN1 
locus, resulting in strain PATW079. The CAN1 locus is 
an endogenous genomic negative selectable marker that 
is commonly used for integrations [22, 23]. The result-
ing strain PATW079 (aro3Δ, ARO4G226S, pdc6Δ, pdc5Δ, 
aro10Δ, can1Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, 
atCHS3↑, coCHS3↑, at4CL3↑, coF3H↑, coGhDFR↑, 
coANS↑, co3GT↑) was cultured in shake-flasks on SM 
medium with glucose as sole carbon source for 144  h. 
HPLC analysis of the culture supernatant and cell pel-
let showed the production of naringenin, phloretic acid, 
Table 2 Product formation in S. cerevisiae strains PATW002, PATW011 and PATW012 in shake flask cultures
These strains express coGhDFR, coMtDFR1 and coAaDFR, respectively in combination with coF3H, coANS, co3GT genes. The strains were grown in shake-flasks with 
50 mL SMNar (1.5 mM naringenin) and extracellular metabolite concentration of dihydrokaempferol (DHK), kaempferol, kaempferol 3-O-glucoside (K3G), pelargonidin 
and pelargonidin 3-O-glucoside (P3G) expressed in µM were measured by HPLC in supernatant sampled after 140 h of cultures at 30 °C. Growth and production time 
courses of extracellular metabolites can be found in Additional file 2. Intracellular concentrations expressed in µmol/gCDW were extracted and measured by HPLC. Data 
represent the average ± mean deviation of independent biological triplicates
– not detected
PATW002 PATW011 PATW012 PATW002 PATW011 PATW012
[Concentration]Ext µM [Concentration]Int µmol/gCDW
DHK 60.7 ± 2.3 77.0 ± 3.1 43.3 ± 0.7 2.25 ± 0.17 1.64 ± 0.18 0.84 ± 0.04
Kaempferol 2.7 ± 0.2 1.5 ± 0.2 5.0 ± 0.2 1.76 ± 0.07 0.55 ± 0.04 1.45 ± 0.05
K3G 50.3 ± 3.6 12.4 ± 0.3 33.3 ± 1.9 1.58 ± 0.14 0.26 ± 0.02 0.49 ± 0.05
Pelargonidin – – – 0.066 ± 0.01 0.019 ± 0.00 0.026 ± 0.00
P3G – – – – – –
Fig. 2 Extracts of cell pellets from S. cerevisiae strains PATW002, 
PATW011 and PATW012. These strains express coGhDFR, coMtDFR1 
and coAaDFR respectively in combination with coF3H, coANS, co3GT 
genes. The strains were grown in SMNar (1.5 mM naringenin) and the 
cell pellets were lyophilized and extracted with acidified methanol
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coumaric acid, as well as DHK, kaempferol, K3G and pel-
argonidin (Table 3).
Deletion of EXG1 and SPR1, genes encoding β‑glucosidases
The imbalance observed in pelargonidin and pelargoni-
din 3-O-glucoside might originate from a poor perfor-
mance of the glucosyltransferase or to the presence of 
native glucosidase activity. We could undeniably confirm 
the activity of the 3-O-glycosyltransferase thanks to the 
detectable concentration of kaempferol 3-O-glucoside 
in the strain PATW079. This might then suggest that 
breakdown of pelargonidin 3-O-glucoside may occur in 
yeast, as previously proposed [24]. Several S. cerevisiae 
glucosidases have been identified that can hydrolyse fla-
vonoid glucosides and convert them back to their agly-
cone form [24]. Significant hydrolysis of anthocyanins, 
including P3G, were catalysed by the translational prod-
uct of the glucosidase genes EXG1 and SPR1. In another 
study, it was shown that the production of the flavo-
noid glucoside scutellarein 7-O-glucoside was increased 
when these glucosidases were deleted [25]. Therefore, 
for our study, the EXG1 and SPR1 genes were deleted in 
the anthocyanin-producing strain PATW079. Each glu-
cosidase was replaced by a gene that will contribute to 
naringenin production and should consequently lead to 
improved pelargonidin and pelargonidin 3-O-glucoside 
production. Previously, it was shown that the introduc-
tion of the tyrosine ammonia lyase (coTAL1) gene from 
Rhodobacter capsulatus, which converts tyrosine into 
coumaric acid (see Fig. 1), together with additional cop-
ies of coCHS3, improved naringenin production [7]. 
Therefore, the EXG1 and SPR1 knockouts were com-
bined with the introduction of an expression cassette 
of codon optimized coCHS3 and coTAL1, respectively, 
resulting in strain PATW080 (aro3Δ, ARO4G226S, pdc6Δ, 
pdc5Δ, aro10Δ, can1Δ, exg1Δ, spr1Δ, atPAL1↑, coC4H↑, 
coCPR1↑, atCHI1↑, atCHS3↑, coCHS3↑, at4CL3↑, 
coF3H↑, coGhDFR↑, coANS↑, co3GT↑, coCHS3↑, 
coTAL1↑). This latter strain was cultivated under shake 
flask conditions using SMG and HPLC analysis of culture 
supernatant and pellet showed that the levels of phloretic 
acid declined, likely due to the presence of an additional 
copy of coCHS3 in PATW080, relative to PATW079, 
while increases were observed in the concentrations of 
DHK, K3G, kaempferol and pelargonidin (Table 3). Inter-
estingly, deletion of EXG1 and SPR1 did not yield signifi-
cant changes in measurable quantities of P3G and did not 
influence the ratio of kaempferol and K3G (Table 3).
Abolishing the competing pathway towards phloretic acid
The formation of phloretic acid as an unwanted by-
product in flavonoid-producing yeast strains is associ-
ated with the presence of the 4-coumaric acid-CoA ligase 
(4CL3) gene, and leads to major losses of carbon enter-
ing the phenylpropanoid pathway [7, 26–28]. Recently, 
S. cerevisiae TSC13 encoding a very long chain fatty acid 
(VLCFA) enoyl reductase was identified as the respon-
sible enzyme for the formation of phloretic acid via 
the reduction of coumaroyl-CoA (Fig.  1) [29]. Replac-
ing TSC13 by MdECR, an ortholog from apple (Malus 
domesticus), was shown to eliminate phloretic acid 
production, while retaining good culture growth, and 
improved production of naringenin [30]. Therefore, the 
TSC13 coding sequence in strain PATW080 was replaced 
with a yeast codon-optimized version of MdECR (coM-
dECR), which resulted in strain PATW076. PATW076 
(aro3Δ, ARO4G226S, pdc6Δ, pdc5Δ, aro10Δ, can1Δ, exg1Δ, 
spr1Δ, tsc13Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, 
Table 3 Product formation in S. cerevisiae strains PATW066, PATW079, PATW080 and PATW076 in shake flask cultures
The strains were grown in shake-flasks with 50 mL SMG and extracellular metabolite concentration of coumaric and phloretic acids, naringenin, dihydrokaempferol 
(DHK), kaempferol, kaempferol 3-O-glucoside (K3G), pelargonidin and pelargonidin 3-O-glucoside (P3G) expressed in µM were measured by HPLC in supernatant 
sampled after 140 h of cultures at 30 °C. Growth and production time courses of extracellular metabolites can be found in Additional file 3. Intracellular concentrations 
expressed µmol/gCDW were extracted and measured by HPLC. Data represent the average ± mean deviation of independent biological triplicates
– not detected
a  Data from [7] (140 h of growth of IMX106)
IMX106a PATW066 PATW079 PATW080 PATW076 PATW079 PATW080 PATW076
[Concentration]Ext µM [Concentration]Int µmol/gCDW
Coumaric acid 25 2.4 ± 0 2.8 ± 0 21.2 ± 9 51.6 ± 5 0.02 ± 0.00 0.24 ± 0.01 0.50 ± 0.02
Phloretic acid 200 167.2 ± 7 200.2 ± 2 139.5 ± 8 – – – –
Naringenin 46.5 40.0 ± 4 1.8 ± 0 1.9 ± 0 3.6 ± 0 0.11 ± 0.07 0.15 ± 0.01 0.32 ± 0.02
DHK – – 28.8 ± 2 33.2 ± 3 92.5 ± 4 0.45 ± 0.04 0.71 ± 0.06 1.71 ± 0.12
Kaempferol – – – 0.3 ± 0 0.6 ± 0 0.11 ± 0.01 0.17 ± 0.03 0.36 ± 0.03
K3G – – 8.3 ± 1 7.5 ± 1 16.1 ± 1 0.09 ± 0.03 0.14 ± 0.02 0.22 ± 0.01
Pelargonidin – – – – – 0.003 ± 0.001 0.005 ± 0.001 0.011 ± 0.002
P3G – – – – – – – –
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atCHS3↑, coCHS3↑, at4CL3↑, coF3H↑, coGhDFR↑, 
coANS↑, co3GT↑, coCHS3↑, coTAL1↑, coMdECR) was 
cultivated under shake-flask conditions using minimal 
medium and compared to PATW079 and PATW080. 
HPLC analysis of the culture supernatants and pellets 
showed that phloretic acid formation was indeed com-
pletely eliminated in PATW076, and the production of 
all other phenolic compounds, including coumaric acid, 
naringenin, dihydrokaempferol, kaempferol, kaempferol 
3-O-glucoside and pelargonidin, was increased by two-
fold relative to PATW080 (Table 3).
Anthocyanin production in controlled aerobic batch 
cultures
For further characterisation of strain PATW076 (aro3Δ, 
ARO4G226S, pdc6Δ, pdc5Δ, aro10Δ, can1Δ, exg1Δ, spr1Δ, 
tsc13Δ, atPAL1↑, coC4H↑, coCPR1↑, atCHI1↑, atCHS3↑, 
coCHS3↑, at4CL3↑, coF3H↑, coGhDFR↑, coANS↑, 
co3GT↑, coCHS3↑, coTAL1↑, coMdECR), this strain was 
grown in aerobic bioreactors operated as batch culture 
in SMG medium (20  g/L glucose) at pH 5.0. The strain 
IMK393 (aro3Δ, ARO4G226S, pdc6Δ, pdc5Δ, aro10Δ) was 
grown in the exact same conditions as a control (Fig. 3). 
In these aerobic cultures, glucose metabolism was pre-
dominantly fermentative producing ethanol, acetate, 
glycerol,  CO2, and biomass, after which the metabolism 
switched towards reconsumption of ethanol, acetate, and 
glycerol (Fig. 3a, b) [31, 32]. The specific growth rates of 
the control strain IMK393 and the flavonoid producing 
PATW076 during the glucose consumption phase were 
0.23 ± 0.02 and 0.18 ± 0.01/h, respectively. These specific 
growth rates were approximately half of specific growth 
rate from the reference strain CEN.PK113-7D, but are 
similar to the growth rate of the naringenin production 
strain IMX198 (described in [7]).
The total sum of extracellular flavonoids at the end of 
glucose consumption phase was only 70.4 ± 9.5 µM, con-
sisting mostly of dihydrokaempferol with 59.9 ± 1.5 µM, 
whereas the concentration of flavonoids reached 
202.3 ± 16.9 µM at the end of the fermentation (Fig. 3c, 
d). Although concentrations of intermediates like cou-
maric acid and naringenin decreased towards the end 
of the fermentation, similar to naringenin intermediates 
in Koopman et  al. [7], the dihydrokaempferol concen-
tration increased throughout the fermentation towards 
151.8 ± 1.9 µM, indicating there is a limiting step towards 
Fig. 3 Growth of IMK393 & PATW076 and flavonoids formation by PATW076 in bioreactors. Growth and extracellular metabolite formation 
were studied in duplicate pH controlled (pH 5.0) and aerobic controlled batch cultures of IMK393 and PATW076 on glucose and auxotrophic 
supplements. a Concentrations of glucose (White circle), ethanol (Black circle), acetate (White square), glycerol (Black square), and optical density 
 (OD660) (Triangle) for IMK393. b Concentrations of glucose (White circle), ethanol (Black circle), acetate (White square), glycerol (Black square), and 
optical density  (OD660) (Triangle) for PATW076. c Concentrations of kaempferol (Black down‑pointing triangle), and kaempferol 3‑O‑glucoside (K3G) 
(Black up‑pointing triangle) for PATW076. d Concentrations of coumaric acid (Times), naringenin (Inverted triangle), dihydrokaempferol (White 
diamond), and the sum of all flavonoids (Black diamond) for PATW076. Results are shown from a single representative experiment
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anthocyanidin and anthocyanin production (Fig.  3d). 
Furthermore, the by-products kaempferol and kaemp-
ferol 3-O-glucoside were excreted to a final concentration 
of 18.3 ± 3.5 µM and 18.3 ± 1.9 µM (Fig. 3c).
Since pelargonidin and pelargonidin 3-O-glucoside 
could not be measured as extracellular metabolites in 
shake flask experiments, biomass samples were taken 
from the bioreactors after complete glucose consump-
tion and after the reconsumption of ethanol for analysis 
of intracellular compounds in the anthocyanin pathway. 
Concentrations of intermediates coumaric acid, nar-
ingenin, and dihydrokaempferol roughly increased 
twice between the end of the glucose and ethanol 
growth phase, whereas concentrations for pelargonidin 
increased approximately four times from 0.002 ± 0.001 
to 0.01 ± 0.002  µmol/gCDW and five times for both 
kaempferol and kaempferol 3-O-glucoside with final 
concentrations of 0.96 ± 0.1 and 0.25 ± 0.01  µmol/gCDW. 
Pelargonidin 3-O-glucoside was estimated from LC–MS 
data to be 0.001 µmol/gCDW (see Additional file 4).
Discussion
In this work we provide a clear proof-of concept for 
the production of a complex plant polyphenol antho-
cyanin in S. cerevisiae. We describe the first example of 
de novo production of pelargonidin and pelargonidin 
3-O-glucoside in baker’s yeast, starting from glucose. To 
establish the anthocyanin biosynthetic pathway in yeast, 
a previously-developed yeast strain with improved aro-
matic amino acid biosynthesis was further engineered 
by integrating fourteen additional genes into its genome. 
Moreover, three endogenous genes were deleted from 
the chassis genome to suppress by-product formation 
and degradation of the end-product. In an aerobic batch 
fermentation experiment, intracellular concentrations of 
0.01 µmol/gCDW pelargonidin could be achieved in these 
cultures.
In previous studies, the production of anthocya-
nin compounds was achieved in E. coli [33]. All work 
described in E.  coli reports on bioconversion of an 
intermediate (e.g. naringenin), which was fed to the cul-
ture. Recently, the complete biosynthesis of anthocya-
nins starting from sugars using E. coli polycultures was 
described [17]. The biosynthesis of anthocyanins was 
distributed between several strains, the first producing 
an intermediate to feed another. This concept demon-
strated to be superior to single strain engineering. How-
ever, the anthocyanin biosynthesis was not completely de 
novo since malonate was fed into the culture. Further-
more, in industrial biotechnology the use of polycultures 
still needs to be developed and will face additional chal-
lenges, while processes using monocultures are stand-
ard. In comparison to yeast, E. coli is not a food-grade 
microorganism and may have limitations in expressing 
cytochrome P450 enzymes for further modifications of 
anthocyanins. Production of anthocyanins by plant cell 
cultures has also been developed [34]. Plant cells in gen-
eral produce complex mixtures of compounds, and are 
difficult to stabilize and engineer. Therefore, we aimed to 
design a single yeast strain capable of producing de novo 
anthocyanins and utilizing a simple carbon source. Dur-
ing review of this manuscript, production of anthocya-
nins in yeast using genes from a wide array of plants was 
published, which further reinforces our observations and 
complements the present study [35].
In previous studies, the de novo production of plant 
polyphenols, such as the flavanone naringenin, the 
stilbene resveratrol and the flavonol kaempferol was 
reported [7, 36, 37]. These achievements were ground-
breaking to demonstrate that it was feasible to produce 
complex high-value phenolic compounds in yeast culture 
supernatants in a relatively simple fermentative set up. 
In the current study, we aimed to extrapolate these find-
ings further towards anthocyanins, which exhibit a broad 
range of applications in the food, cosmetics and health 
sectors. Therefore it is an important observation that we 
can produce such anthocyanins in a fermentation system, 
albeit at levels that are as yet suboptimal and lower than 
their precursor molecule naringenin.
In spite several attempts to improve the synthesis of 
pelargonidin and its glycosylated form, including positive 
elimination of phloretic acid formation and deletion of 
endogenous glucosidases, it was obvious that many meta-
bolic bottlenecks still occur and limit yet exploitation of 
these strains. Overcoming these current limitations has 
huge potential to increase overall end product yield. A 
major bottleneck in the production of anthocyanins is 
located in the steps after the formation of dihydrokaemp-
ferol from naringenin. It is clear that the majority of the 
naringenin formed is converted to dihydrokaempferol, 
indicating that F3H is functioning well (Tables 2 and 3). 
However, the enzymes responsible for the subsequent 
steps towards anthocyanin, DFR and ANS, clearly func-
tion less efficiently in the pathway.
The most obvious candidate for improvement is the 
DFR enzyme. A limited number of DFR enzymes from 
different plants have been tested, and only some of them 
were capable of converting dihydrokaempferol to leu-
copelargonidin. When comparing the efficiency of three 
of these DFRs in S. cerevisiae, only minor differences in 
(low) efficiency were observed (Table  2), indicating that 
the DFR reaction is not performing well in yeast. Simi-
lar observations have been made before, in prokaryotic 
hosts such as E. coli [38]. The background to this appar-
ent malfunctioning of DFRs in microbial systems could 
relate to the exceptional level of substrate inhibition 
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known to be characteristic for this enzyme. Trabelsi et al. 
have described a detailed study on kinetic parameters of 
the DFR enzyme from Vitis vinifera (VvDFR), and have 
observed that high concentrations of substrate (dihydro-
quercetin in the case of VvDFR) lead to the formation of 
dead-end enzyme–substrate complexes [39, 40]. Indeed, 
in our system we observe high concentrations of dihy-
drokaempferol. Therefore, regulating the expression of 
the F3H enzyme may be necessary to achieve optimal 
concentrations of dihydrokaempferol in order for DFR to 
function effectively without inhibition. Another explana-
tion could be the findings of Halbwirth et al. that, in the 
presence of excess amounts of leucoanthocyanidin, DFR 
might catalyse the reverse reaction to form dihydrofla-
vonols from leucoanthocyanidins [41, 42].
The ANS enzyme used in this study is known to be able 
to catalyse the conversion of dihydroflavonols into fla-
vonols, and the conversion of 2S-naringenin into kaemp-
ferol [43, 44]. It is therefore very likely to be responsible 
for producing kaempferol as a side product [12]. A dif-
ferent choice of source for the ANS enzyme may lead to a 
higher specificity of the microbial production system for 
anthocyanins, although all characterized ANS proteins 
have been observed to have this side activity [13]. ANS 
requires ferrous iron and 2-oxoglutarate for full activity. 
In vitro studies showed that ascorbic acid is also required 
or at least beneficial for activity of ANS [45, 46]. There-
fore, supplementing the medium with ascorbic acid may 
improve ANS activity in vivo.
The performance of the glucosyltransferase 3GT in 
this work is still unclear. The production of kaemp-
ferol 3-O-glucoside is clearly observed, which confirms 
the presence of 3GT activity. In Table  3, the levels of 
kaempferol 3-O-glucoside are consistently equivalent to 
the levels of kaempferol, indicating satisfactory gluco-
syltransferase activity. On the other hand, pelargonidin 
3-O-glucoside was in all cases much lower in concentra-
tion (if detectable at all) than its aglycone. In Arabidop-
sis, the 3GT (gene At5g17050) is known to play a crucial 
role in anthocyanin biosynthesis, since its deletion from 
the Arabidopsis genome results in strong reductions 
in anthocyanin accumulation in this plant [47]. Fur-
thermore, in  vitro enzyme assays have shown that this 
enzyme is able to mediate pelargonidin glycosylation 
[47]. An alternative explanation for the lack of P3G could 
be offered by the presence of glucosidases in yeast that 
specifically degrade pelargonidin 3-O-glucoside once it 
has been formed, as has been suggested by [24, 25]. How-
ever, deletion of the two enzymes that display the high-
est deglycosylation activity on P3G in in vitro assays did 
not result in increased pelargonidin 3-O-glucoside levels 
(Table 3). Possibly, other glucosidases exist in yeast that 
can also act on pelargonidin 3-O-glucoside, which have 
yet to be identified. Alternatively, 3GT enzymes with a 
higher specific activity on pelargonidin would need to be 
expressed in yeast. Wellmann et al. described that a 3GT 
from strawberry dramatically reduced the main reaction 
of ANS towards a catechin dimer when feeding the mon-
omeric catechin in an in vitro enzyme assay [10]. Instead, 
the major product was the cyanidin 3-O-glucoside, while 
without the recombinant 3GT the respective aglycone 
cyanidin was only a minor product. Such a “pull” effect 
can, most probably, increase the flux towards the antho-
cyanin in yeast also.
Local concentrations of naringenin may also play a 
role in the limited production of pelargonidin. Though 
only a small fraction of de novo produced naringenin 
is finally converted into pelargonidin and pelargonidin 
3-O-glucoside, production of these anthocyanin com-
pounds may be increased by additional supplementation 
of naringenin to the culture. Also, boosting of de novo 
naringenin production, by preventing phloretic acid pro-
duction through gene replacement of TSC13 [30], indeed 
resulted in higher yields of pelargonidin (Table 3).
Anthocyanins, such as pelargonidin 3-O-glucoside and 
its aglycon, are distinguished from other polyphenols in 
that they are apparently not secreted into the medium. 
In previous work, compounds like naringenin and res-
veratrol could readily be recovered from the medium [7, 
26]. Also, in the current work, dihydrokaempferol and 
kaempferol 3-O-glucoside were found in the medium. 
However, here, pelargonidin and pelargonidin 3-O-glu-
coside could not be detected in the medium, even when 
using sensitive LC–MS technology. Possibly, the positive 
charge of anthocyanins prevents their secretion through 
the secretion channels that export other polyphenols 
from yeast. Clearly, anthocyanin accumulation in the 
medium would be much preferred for easy recovery of 
the pigments from yeast cultures.
Conclusions
Here we report that S. cerevisiae could be engineered for 
the de novo production of pelargonidin and pelargonidin 
3-O-glucoside by expressing PAL, TAL, C4H, CPR, 4CL, 
CHS, CHI, F3H, DFR, ANS and 3GT. At the same time, 
a number of potential metabolic bottlenecks have been 
identified, ranging from enzyme kinetics and specificity, 
to anthocyanin export. Solving these will have a direct 
major impact on the efficiency of the system and are 
important targets for future attempts to promote yeast 
as a production system for anthocyanin pigments. Other 
plant pigments, such as carotenoids and betalains, have 
already been successfully produced in yeast [48, 49], and 
the results generated in this work represent an important 
framework for future development and sustainable pro-
duction of this category of plant secondary metabolites.
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Methods
Strains and maintenance
All S. cerevisiae strains used in this study (Table  4) 
are derived from strain IMK393 [7]. In general, yeast 
strains were grown on synthetic medium (6.7  g/L yeast 
nitrogen base without amino acids) with 20 g/L glucose 
(SMG) and appropriate growth factors to supplement 
the specific auxotrophic requirements of the strains 
(20 mg/L uracil, 20 mg/L histidine, 20 mg/L tryptophan 
and 120  mg/L leucine). Strains harbouring plasmids 
pCPW002, pCPW006 and pCPW007 were grown in the 
above medium supplemented with 1.5  mM naringenin 
(SMNar). Glycerol stocks were prepared by adding a final 
concentration of 20% glycerol to the culture and 1.5 mL 
aliquots were stored at − 80 °C.
E. coli DH5α electrocompetent cells were used for bac-
terial transformations. For plasmid propagation, E. coli 
DH5α cells were cultured in LB medium supplemented 
with ampicillin (100 mg/L) at 37 °C with 250 rpm agita-
tion. Solid medium was obtained by addition of 15  g/L 
agar.
Media and cultivations
Shake flask cultures were grown in 250  mL baffled 
shake flasks with 50  mL SMG medium at 30  °C while 
shaking at 250  rpm. The shake flasks were inoculated 
to an  OD600 of 0.2 with cells, resuspended in 2  mL of 
medium, obtained from a pre-culture grown in similar 
conditions. Samples of 1 mL were taken in time to fol-
low growth and product formation. Optical density was 
measured at 600 nm using an Ultraspec 10 cell density 
meter (Amersham Biosciences).
Aerobic batch cultures were performed in 2-L biore-
actors (Applikon, Delft, The Netherlands) using a work-
ing volume of 1.4 L. The bioreactors were filled with 
synthetic medium with extra nitrogen source (SMN). 
SMN contained 3  g/L  KH2PO4, 0.5  g/L  MgSO4·7H2O, 
and trace elements [50] and 10  g/L  (NH4)2SO4 [7]. 
After heat sterilization of the bioreactors, 20  g/L glu-
cose, 0.2 g/L antifoam C (Sigma-Aldrich, Zwijndrecht, 
The Netherlands), and filter-sterilized vitamins solu-
tion [50] were added. To sustain growth of the auxo-
trophic strains, the medium was further supplemented 
with a filter-sterilized mixture to a final concentration 
of 150 mg/L uracil, 500 mg/L leucine, 75 mg/L trypto-
phan, and 125 mg/L histidine [51, 52]. The bioreactors 
were inoculated from exponentially growing cells in 
pre-culture flasks containing 100 mL of SMN to an ini-
tial  OD660nm of 0.2. The aerobic batch cultivations were 
performed at 30  °C and at a stirrer speed of 800  rpm. 
The culture pH was maintained at 5.0 by automated 
addition of 2 M KOH and pressurized air was sparged 
through the bioreactors at 0.7 L/min.
Table 4 Saccharomyces cerevisiae strains used in this study
Name Relevant genotype Contains plasmid Origin
IMK393 MATalpha ura3‑52 his3‑Δ1 leu2‑3112 trp1‑289MAL2‑8cSUC2 Δaro3::loxP ARO4G226S pdc6Δ::loxP 
pdc5Δ::loxP aro10Δ::loxP
[7]
IMX106 IMK393 pyk2Δ::LEU2‑TDH3P‑atCHI1‑CYC1T TPI1p‑atCHS3‑ADH1T, TEF1P‑at4CL3‑TEF1T pUDE172 [7]
IMX106‑F IMX106 pF This study
IMX106‑FD IMX106 pFD This study
IMX106‑FDA IMX106 pFDA This study
IMX106‑FDA3 IMX106 pFDA3 This study
PATW002 IMK393 pCPW002 This study
PATW003 IMK393 p414‑TEF1p‑Cas9‑CYC1t This study
PATW004 PATW003 X‑2::TEF1P‑At4CL3‑TEF1T TPI1P‑AtCHS3‑ADH1T TDH3P‑AtCHI1‑CYC1T p414‑TEF1p‑Cas9‑CYC1t This study
PATW005 PATW004 XII‑2::TDH3P‑AtPAL1‑CYC1T TPI1P‑coC4H‑ADH1T PGI1P‑coCPR1‑PGI1T TEF1P‑coCHS3‑TEF1T p414‑TEF1p‑Cas9‑CYC1t This study
PATW006 PATW005 can1Δ::GAP1P‑coF3H‑TEF1T TPI1P‑coANS‑PGK1T TEF1P‑coGhDFR‑CYC1T PGI1P‑co3GT‑ADH1T p414‑TEF1p‑Cas9‑CYC1t This study
PATW011 IMK393 pCPW006 This study
PATW012 IMK393 pCPW007 This study
PATW034 PATW006 exg1Δ::TEF1P‑coCHS3‑TEF1T p414‑TEF1p‑Cas9‑CYC1t This study
PATW044 PATW034 spr1Δ::TDH3P‑coTAL1‑CYC1T p414‑TEF1p‑Cas9‑CYC1t This study
PATW066 PATW005 This study
PATW072 PATW044 tsc13Δ::TSC13P‑coMdERC‑TSC13T p414‑TEF1p‑Cas9‑CYC1t This study
PATW079 PATW006 This study
PATW080 PATW044 This study
PATW076 PATW072 This study
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Plasmid and strain construction
All primers were supplied by IDT and are listed in a table 
(see Additional file 5). Preparative PCRs for cloning were 
performed using Q5 High-Fidelity DNA Polymerase 
(New England BioLabs). PCR conditions were adapted to 
the guidelines of the respective manufacturer. Restriction 
enzymes were obtained from Thermo Fisher Scientific 
and used according to the manufacturer’s instructions. 
PCR products were purified by using the  NucleoSpin® 
Gel and PCR Clean-up kit. Plasmids were isolated from 
E. coli DH5α overnight cultures using the  NucleoSpin® 
Plasmid EasyPure kit. DNA and plasmid isolation from 
S. cerevisiae was performed as previously described [53]. 
All yeast transformations were done using standard Lith-
ium acetate methods according to [54].
The codon optimized genes of A. thaliana F3H 
(coF3H; Accession number: NP_190692), ANS (coANS; 
NP_194019), UGT78D2 (co3GT; NP_197207), and G. 
hybrida DFR (coGhDFR; P51105) were ordered as syn-
thetic genes (Genscript) as promoter, ORF termina-
tor constructs. Codon optimization was performed 
using the Jcat algorithm [55]. For assembling them into 
plasmids, promoter-ORF-terminator fragments were 
amplified using Q5 polymerase (NEB) with primers 
that carried a restriction site at the 5′-end to facilitate 
cloning of the PCR products into vector pAT423 or 
p424_GPD (Table  5). The vectors pF, pD, p3GT, pFD, 
pFDA and pFDA3 were made by using in vivo homol-
ogous recombination in S. cerevisiae and by standard 
restriction ligation cloning (Table  5). Each construct 
Table 5 Plasmids used in this study
Name Relevant characteristics Origin
p414‑TEF1p‑Cas9‑CYC1t Centromeric plasmid, AmpR, TRP1, TEF1p‑Cas9‑CYC1t [22]; Addgene#43802
p426‑SNR52p‑gRNA.CAN1.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑CAN1.Y [22]; Addgene#43803
p426‑SNR52p‑gRNA.X‑2.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑X‑2.Y This study
p426‑SNR52p‑gRNA.XII‑2.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑XII‑2.Y This study
p426‑SNR52p‑gRNA.SPR1.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑SPR1.Y This study
p426‑SNR52p‑gRNA.EXG1.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑EXG1.Y This study
p426‑SNR52p‑gRNA.TSC13.Y‑SUP4t 2 μm ori, AmpR, URA3, gRNA‑TSC13.Y This study
pESC‑TRP Template for A‑TRP1‑B Agilent
p424_GPD 2 μm ori, AmpR, TRP1 [57]
pAT423 2 μm ori, AmpR, HIS3 [58]
pF pAT423, TDHP‑coF3H‑TDHT This study
pD pAT423, TDHP‑coGhDFR‑TDHT This study
p3GT p424_GPD, PGI1P‑co3GT‑CYC T This study
pFD pAT423, ADHP‑coF3H‑ADHT, TDHP‑coGhDFR‑TDHT This study
pFDA pAT423, GPDP‑coF3H‑TEFT, TDHP‑coGhDFR‑TDHT, ADHP‑coANS‑ADHT This study
pFDA3 pAT423, GPDP‑coF3H‑TEFT, TDHP‑coGhDFR‑TDHT, ADHP‑coANS‑ADHT, PGI1P‑co3GT‑CYC T This study
pUC57 + AtF3HBN Template for B‑GPDP‑coF3H‑TEF1P‑N Synthetic construct
pUC57 + AtANSNF Template for N‑TPIP‑coANS‑PGKT‑F Synthetic construct
pUC57 + 2 µmFG Template for F‑2µm‑G Synthetic construct
pUC57 + GhDFRGO Template for G‑TEF1P‑coGhDFR‑CYC1P‑O Synthetic construct
pUC57 + MtDFRGO Template for G‑TEF1P‑coMtDFR‑CYC1P‑O Synthetic construct
pUC57 + AaDFRGO Template for G‑TEF1P‑coAaDFR‑CYC1P‑O Synthetic construct
pUC57 + At3GTOI Template for O‑PGI1P‑co3GT‑ADHT‑I Synthetic construct
pUDE172 Template for TDH3P‑atPAL1‑CYC1T, TPIP‑coC4H‑ADHT, PGIP‑coCPR1‑PGIT [7]
pUDE188 Template for TDH3P‑coCHS3‑CYC1T, TEF1P‑coCHS3‑TEF1P, I‑E. coli‑A [7]
pUDI065 Template for TDH3P‑atCHI1‑CYC1T, TPIP‑atCHS3‑ADHT, TEFP‑at4CL3‑TEFT [7]
pUDI069 Template for TDH3P‑coTAL1‑CYC1T [7]
pCPW002 2 μm ori, AmpR, TRP1, PGAP1‑AtF3H‑TTEF1, TPIP‑coANS‑PGKT, TEF1P‑coGhDFR‑CYC1P, PGI1P‑
co3GT‑ADHT
This study
pCPW006 2 μm ori, AmpR, TRP1, PGAP1‑AtF3H‑TTEF1, TPIP‑coANS‑PGKT, TEF1P‑coMtDFR‑CYC1P, PGI1P‑
co3GT‑ADHT
This study
pCPW007 2 μm ori, AmpR, TRP1, PGAP1‑AtF3H‑TTEF1, TPIP‑coANS‑PGKT, TEF1P‑coAaDFR‑CYC1P, PGI1P‑
co3GT‑ADHT
This study
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was verified by DNA sequencing. Strain IMX106 was 
transformed with the different constructs pF, pFD, 
pFDA and pFDA3, resulting in strains IMX106-F, 
IMX106-FD, IMX106-FDA, IMX106-FDA3, respec-
tively (Table 4).
The episomal expression vectors pCPW002, pCPW006 
and pCPW007 were assembled in vivo using 60 bp syn-
thetic homologous recombination sequences [56]. The 
M. truncatula DFR (coMtDFR; XP_013466134) and A. 
andreanum DFR (coAaDFR; AAP20866) genes were 
ordered as yeast codon-optimized synthetic constructs. 
Gene fragments coF3HBN, coANSNF, 2 µmFG, coGhDFRGO, 
coMtDFRGO, coAaDFRGO, and co3GTOI were synthesized 
by GenScript. The fragments TRPAB and E. coliIA were 
amplified from pESC-TRP to pUDE188, respectively. 
Correct assembly of the plasmids was confirmed via 
restriction enzyme analysis and sequencing (Macrogen). 
Strain IMK393 was transformed with the different con-
structs pCPW002, pCPW006 and pCPW007, resulting 
in strains PATW002, PATW011 and PATW012, respec-
tively (Table 4).
Integration of gene fragments and knock-out of genes 
was obtained by using the p414-TEF1p-Cas9-CYC1t and 
p426-SNR52p-gRNA.CAN1.Y-SUP4t plasmids, as previ-
ously described [22]. The Yeastriction webtool was used 
to select for specific gRNA targeting sites in S. cerevisiae 
loci [59]. The gRNA Designer software of ATUM (https 
://www.atum.bio/eComm erce/cas9/input ) was used to 
select for specific gRNA targeting sites in S. cerevisiae 
genomic regions. New gRNA target sequences were 
introduced in the template plasmid p426-SNR52p-gRNA.
CAN1.Y-SUP4t by extension PCR. Primers containing 
the new gRNA target sequence were used in combination 
with primers ML009/ML010 in the 2  µm ori, creating 
two DNA fragments with minimally 60 bp overlaps. Both 
fragments were transformed to S. cerevisiae for in  vivo 
assembly. The new gRNA plasmid was isolated from S. 
cerevisiae and transformed into E. coli. Plasmid was iso-
lated from E. coli and correct replacement of the gRNA 
target sequence was confirmed via sequencing using 
primers ML017/018.
In general, for each new integration, an S. cerevisiae 
strain containing the p414-TEF1p-Cas9-CYC1t plasmid 
was transformed with a gRNA plasmid and integration 
fragment(s). Each integration fragment contained 60  bp 
overlaps upstream and downstream of the double strand 
break. In case of a gene knockout, at least 300 bp of the 
target gene sequence was deleted. Before each next inte-
gration, the gRNA plasmid was removed by growing the 
strain on liquid rich medium and plating on non-selec-
tive medium, subsequently, plasmid removal was con-
firmed by restreaking the same colony on selective and 
non-selective medium. Both gRNA and Cas9 plasmids 
were removed before strains were analysed in culturing 
experiments.
Saccharomyces cerevisiae strain IMK393 was trans-
formed with p414-TEF1p-Cas9-CYC1t yielding strain 
PATW003. The expression cassette at4CL3-atCHI1-
atCHS3 for genomic integration was amplified using 
primers CP85/86 from plasmid pUDI065. Strain 
PATW003 was transformed with the gRNA.X-2 plasmid 
and the at4CL3-atCHI1-atCHS3 integration fragment. 
Correct integration was verified by colony PCR and 
sequencing. After gRNA plasmid removal, this resulted 
in strain PATW004. The expression cassettes atPAL1-
coC4H-coCPR1 and coCHS3 for genomic integration 
were amplified from plasmids pUDE172 and pUDE188 
using, respectively, primers CP87/88 and CP89/90. 
Strain PATW004 was transformed with the gRNA.XII-2 
plasmid and the atPAL1-coC4H-coCPR1 and coCHS3 
integration fragments. Correct integration was verified 
by colony PCR and sequencing. After gRNA and Cas9 
plasmid removal this resulted in strains PATW005 and 
PATW066, respectively.
The expression cassettes coGhDFR-co3GT and coF3H-
coANS for genomic integration were amplified from 
plasmid pCPW002 using primers CP81/82 and CP83/84, 
respectively. Strain PATW005 was transformed with 
the gRNA.CAN1 plasmid and the coGhDFR-co3GT and 
coF3H-coANS integration fragments. Correct integra-
tion was verified by colony PCR and sequencing. After 
gRNA and Cas9 plasmid removal this resulted in strains 
PATW006 and PATW079, respectively.
The EXG1 and SPR1 knockouts were combined with 
introducing coCHS3 and coTAL1 (from R. capsulatus; 
WP_013066811). The expression cassette of coCHS3 
for genomic integration was amplified using primers 
CP166/167 from plasmid pUDE188. Strain PATW006 
was transformed with the gRNA.EXG1 plasmid and the 
coCHS3 integration fragment. Correct integration was 
verified by colony PCR and sequencing. After gRNA 
plasmid removal, this resulted in strain PATW034. The 
expression cassette coTAL1 for genomic integration 
was amplified using primers CP168/169 from plasmid 
pUDI069. Strain PATW034 was transformed with the 
gRNA.SPR1 plasmid and the coTAL1 integration frag-
ment. Correct integration was verified by colony PCR 
and sequencing. After gRNA and Cas9 plasmid removal 
this resulted in strains PATW044 and PATW080, 
respectively.
The native open reading frame (ORF) of TSC13 was 
replaced by its gene homologue from M. domestica 
(MdECR; accession XP_008382818), leaving the native 
TSC13 promoter and terminator intact. A yeast codon 
optimized MdECR gBlock gene fragment (coMdECR) 
was ordered from Integrated DNA Technologies. The 
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coMdECR gene was amplified using primers CP182/183. 
Strain PATW044 was transformed with the gRNA.TSC13 
plasmid and the coMdECR integration fragment. Correct 
integration of coMdECR was verified by colony PCR and 
sequencing. After gRNA and Cas9 plasmid removal this 
resulted in strains PATW072 and PATW076, respectively.
Analytical methods
For product analysis of IMX106 strains, they were grown 
in 10 mL of synthetic dropout medium and incubated at 
30  °C while shaking for 65  h. The cultures were mixed 
with 3 mL of acidified methanol (1% HCl) and frozen in 
liquid nitrogen. The cultures were lyophilized and the 
dried pellet was dissolved in 1  mL 80% methanol and 
20 µL of the sample was analysed by HPLC. HPLC was 
carried out with a Nucleodur 100-5 C18 ec column on a 
1298 Infinity HPLC System (Agilent Technologies). The 
mobile phase consisted of a gradient of solvent A (water 
with 0.1% p-phosphoric acid) and solvent B (acetoni-
trile with 0.1% phosphoric acid). The sample run was 
programmed as followed: gradient to 50% B for 25 min, 
isocratic elution of 50% B, gradient to 100% for 7  min 
and re-equilibration with 100% A for 5 min. The conver-
sion of colourless leucopelargonidin to pelargonidin was 
achieved by acidification with 1% butanol/HCl and sub-
sequent incubation for 5 min at 95 °C according to Reddy 
[60]. The resulting anthocyanidin was concentrated in an 
isoamyl alcohol phase for visualisation.
Optical density of shake flask experiments was meas-
ured at 600 nm using an Ultraspec 10 cell density meter 
(Amersham Biosciences). Glucose, ethanol, glycerol and 
acetate were analyzed by HPLC using an ICS5000 HPLC 
system (Thermo Scientific) equipped with a Dionex DP 
pump, Dionex AS-AP autosampler, Dionex VWD UV 
detector operated at 210  nm and Shodex RI detector 
operated at 35 °C. An Aminex HPX-87H cation-exchange 
column was used with a mobile phase of 0.16 N  H2SO4 
and was operated at 0.8  mL/min and 60  °C. 10  mM 
dimethylsulfoxide in 0.04 N  H2SO4 was used as internal 
standard.
Optical density of bioreactor cultivations was meas-
ured by using a Jenway 7200 spectrophotometer (Jen-
way, Staffordshire, United Kingdom) at 660  nm. Cell 
dry weights were determined via filtration of 10 mL of 
well-mixed sample over dry nitrocellulose membrane 
filters with a pore size of 0.45  µm (Pall Corporation, 
Port Washington, NY). Filters were washed three times 
with demineralized water and dried in a microwave 
oven for 20 min at 360 W. For analysis of carbon diox-
ide production and oxygen consumption in the bio-
reactor, the off-gas was first cooled with a condenser 
(2  °C) and dried with a Permapure MD-110-48P-4 
dryer (Perma pure, Lakewood, NJ), after which  CO2 
and  O2 concentrations in the off-gas were measured 
with a NGA 2000 Rosemount gas analyser (Rosemount 
Analytical, Irvine, CA). Supernatant was obtained via 
centrifugation of the culture broth, which was subse-
quently measured via high-performance liquid chroma-
tography (HPLC) on an Agilent 1260 Infinity (Agilent 
Technologies, Santa Clara, CA) fitted with an Aminex 
HPX-87H ion exchange column (Bio-Rad, Hercules, 
CA) operated at 60  °C with 5  mM  H2SO4 as mobile 
phase at a flow rate of 0.6  mL/min. Detection was of 
extracellular metabolites was done by an Agilent 1260 
refractive-index detector and an Agilent 1260 VWD 
detector. Corrections for ethanol evaporation were cal-
culated according to [52].
For measurement of extracellular phenylpropanoic 
and flavonoid compounds in shake flask and bioreac-
tor experiments, culture samples were diluted with an 
equal volume of 100% ethanol. After vigorous mixing, 
cells were centrifuged at maximum speed in a microcen-
trifuge for 10  min. The supernatant was analysed using 
HPLC. Caffeic acid in 100% ethanol was used as internal 
standard. For intracellular phenylpropanoic and flavo-
noid compounds, cell pellets were resuspended in 2 mL 
acidified methanol (0.75% HCl) and stored at − 80 °C for 
24 h. Next, the samples were lyophilized for 24 h using an 
Edwards Modulyo freeze drier at − 40 °C. The dried pel-
let was resuspended in 2 mL acidified methanol (2% HCl) 
and stored overnight at − 80  °C. The cell pellet samples 
were centrifuged at maximum speed in a microcentrifuge 
at 4  °C for 10  min. The supernatant was analysed using 
HPLC.
For phenylpropanoic and flavonoid compounds, meas-
urements were made using a Waters 2695 HPLC and 
UV absorbance was performed with a Waters 2996 pho-
todiode array detector. Coumaric acid, phloretic acid, 
naringenin, dihydrokaempferol, kaempferol, kaempferol 
3-O-glucoside, pelargonidin and pelargonidin 3-O-glu-
coside were measured, respectively at 312, 280, 280, 360, 
360, 510 and 510 nm using a Luna C18(2) analytical col-
umn (2.0 × 150 mm, 100 Å, particle size 4 μm; Phenom-
enex) operating at 40  °C. Eluent A, ultra-pure water: 
formic acid (1000:1, v/v), and eluent B, acetonitrile: for-
mic acid (1000:1, v/v) were used at a total flow rate of 
0.19 mL/min. The gradient started at 5% B and increased 
linearly to 35% B over 45 min; afterward the column was 
washed with 75% B and equilibrated at 5% A for 15 min 
before the next injection. LC–MS analysis was performed 
as previously described [61].
Coumaric acid, caffeic acid, phloretic acid, naringenin, 
dihydrokaempferol, kaempferol 3-O-glucoside and pel-
argonidin standards were obtained from Sigma Aldrich 
(Zwijndrecht, The Netherlands). Kaempferol and pelar-
gonidin 3-O-glucoside standards were obtained from, 
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respectively Cayman Chemical (Ann Arbor, Michigan, 
USA) and Extrasynthese (Lyon, France).
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